Slide background




Some Industrial Chemicals: IARC Volume115 (2018)

ID 7017 | | Visite: 2020 | Documenti Sicurezza EntiPermalink: https://www.certifico.com/id/7017

IARC Volume115

Some Industrial Chemicals: IARC Volume115 (2018)

This one-hundred-and-fifteenth volume of the IARC Monographs contains evaluations of the carcinogenic hazard to humans of seven industrial chemicals to which workers or the general population are or can be potentially exposed.

n. Agent CAS IARC
1. N,N-dimethylformamide 68-12-2  Group 2A
2. 2-mercaptobenzothiazole 149-30-4 Group 2A 
3. hydrazine 302-01-2 Group 2A
4. tetrabromobisphenol A 79-94-7 Group 2A
5. 1-bromopropane 106-94-5 Group 2B
6. 3-chloro-2-methylpropene 563-47-3 Group 2B
7. N,N-dimethyl-p-toluidine  99-97-8 Group 2B 

All seven agents were accorded high or medium priority for evaluation in the IARC Monographs programme by an Advisory Group that met in 2014 (Straif et al., 2014). 3-Chloro-2-methylpropene was evaluated previously in Volume 63 of the IARC Monographs (IARC, 1995) as not classifiable as to its carcinogenicity to humans (Group 3). Hydrazine was evaluated previously as possibly carcinogenic to humans (Group 2B) and N,N-dimethylformamide as not classifiable as to its carcinogenicity to humans (Group 3) in Volume 71 of the IARC Monographs (IARC, 1999).
Since the previous evaluations, new data have become available. A summary of the findings of this volume appears in The Lancet Oncology (Grosse et al., 2016).

High production volume chemicals and exposure measurement data
Four “high production volume” chemicals (N,N-dimethyl-p-toluidine, 2-mercaptobenzothiazole, tetrabromobisphenol A, and N,N-dimethylformamide) were evaluated. The Working Group noted that for two of these (N,N-dimethyl-p-toluidine and 2-mercaptobenzothiazole) no data on exposure measurement were available in occupational settings or the general population.
Data on exposure measurement were also lacking for two other chemicals evaluated in the present volume (3-chloro-2-methylpropene and
hydrazine).

Isoniazid
Hydrazine is a metabolite of isonicotinic acid hydrazide (isoniazid), which was evaluated in Supplement 7 of the IARC Monographs as not
classifiable as to its carcinogenicity to humans (Group 3) (IARC, 1987). Data on hydrazine and its metabolites from studies on isoniazid and isoniazid metabolites are included in Section 4 of the monograph on hydrazine, but isoniazid was not re-evaluated.

IARC 2018

_______

The agent is described according to the wording of one of the following categories, and the designated group is given. The categorization
of an agent is a matter of scientific judgement that reflects the strength of the evidence derived from studies in humans and in experimental animals and from mechanistic and other relevant data.

Group 1: The agent is carcinogenic to humans.
This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent acts through a relevant mechanism of carcinogenicity. Group 2. This category includes agents for which, at one extreme, the degree of evidence of carcinogenicity in humans is almost sufficient, as well as those for which, at the other extreme, there are no human data but for which there is evidence of carcinogenicity in experimental animals. Agents are assigned to either Group 2A (probably carcinogenic to humans) or Group 2B (possibly carcinogenic to humans) on the basis of epidemiological and experimental evidence of carcinogenicity and mechanistic and other relevant data. The terms probably carcinogenic and possibly carcinogenic have no quantitative significance and are used simply as descriptors of different levels of evidence of human carcinogenicity, with probably carcinogenic signifying a higher level of evidence than possibly carcinogenic.

Group 2A: The agent is probably carcinogenic to humans.
This category is used when there is limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals. In some cases, an agent may be classified in this category when there is inadequate evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals and strong evidence that the carcinogenesis is mediated by a mechanism that also operates in humans. Exceptionally, an agent may be classified in this category solely on the basis of limited evidence of carcinogenicity in humans. An agent may be assigned to this category if it clearly belongs, based on mechanistic considerations, to a class of agents for which one or more members have been classified in Group 1 or Group 2A.

Group 2B: The agent is possibly carcinogenic to humans.
This category is used for agents for which there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals. It may also be used when there is inadequate evidence of carcinogenicity in humans but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, an agent for which there is inadequate evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals together with supporting evidence from mechanistic and other relevant data may be placed in this group. An agent may be classified in this category solely on the basis of strong evidence from mechanistic and other relevant data.

Group 3: The agent is not classifiable as to its carcinogenicity to humans.
This category is used most commonly for agents for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents that do not fall into any other group are also placed in this category. An evaluation in Group 3 is not a determination of non-carcinogenicity or overall safety. It often means that further research is needed, Preamble 31 especially when exposures are widespread or the cancer data are consistent with differing interpretations.

Group 4: The agent is probably not carcinogenic to humans.
This category is used for agents for which there is evidence suggesting lack of carcinogenicity in humans and in experimental animals. In some instances, agents for which there is inadequate evidence of carcinogenicity in humans but evidence suggesting lack of carcinogenicity in experimental animals, consistently and strongly supported by a broad range of mechanistic and other relevant data, may be classified in this group.

DescrizioneLinguaDimensioneDownloads
Scarica questo file (07. N,N-Dimethyl-p-toluidine - CAS 99-97-8.pdf)07. N,N-Dimethyl-p-toluidine - CAS 99-97-8
IARC Volume115 (2018)
EN319 kB2768
Scarica questo file (06. 3-Chloro-2-methylpropene - CAS 563-47-3.pdf)06. 3-Chloro-2-methylpropene - CAS 563-47-3
 
EN231 kB987
Scarica questo file (05. 1-Bromopropane - CAS 106-94-5.pdf)05. 1-Bromopropane - CAS 106-94-5
IARC Volume115 (2018)
EN523 kB802
Scarica questo file (04. Tetrabromobisphenol A - CAS 79-94-7.pdf)04. Tetrabromobisphenol A - CAS 79-94-7
IARC Volume115 (2018)
EN744 kB822
Scarica questo file (03. Hydrazine - CAS 302-01-2.pdf)03. Hydrazine - CAS 302-01-2
IARC Volume115 (2018)
EN683 kB712
Scarica questo file (02. 2-mercaptobenzothiazole - CAS 149-30-4.pdf)02. 2-mercaptobenzothiazole - CAS 149-30-4
IARC Volume115 (2018)
EN393 kB2244
Scarica questo file (01. N,N-Dimethylformamide - CAS 68-12-2.pdf)01. N,N-Dimethylformamide - CAS 68-12-2
IARC Volume115 (2018)
EN784 kB714
Scarica questo file (IARC Volume115.pdf)IARC Volume115
IARC 2018
IT4056 kB587

Tags: Chemicals Safety

Ultimi archiviati Sicurezza

Dic 04, 2022 83

Sentenza CP Sez. 4 n. 23936 del 23 giugno 2010

Sentenza CP Sez. 4 n. 23936 del 23 giugno 2010 Il datore di lavoro durante il montaggio di un ponteggio è tenuto a garantire la presenza di un preposto incaricato specificatamente di sovrintendere alle operazioni di montaggio. Non è sufficiente adempiere a questo obbligo con la presenza in cantiere… Leggi tutto
Dic 02, 2022 35

Decreto direttoriale MLPS n. 13 del 16 marzo 2017

Decreto direttoriale MLPS n. 13 del 16 marzo 2017 Istituzione Gruppo di lavoro tecnico con funzioni consultive per l’esame della documentazione relativa al rilascio delle autorizzazioni di cui all’articolo 131 del decreto legislativo 9 aprile 2008, n. 81. [box-warning]Ricostituzione Decreto… Leggi tutto
Dic 02, 2022 42

Circolare MLPS 8 giugno 2010 n. 18

Circolare MLPS 8 giugno 2010 n. 18 Articolo 131 del D.Lgs. 9 aprile 2008, n. 81 e s.m.i. - Autorizzazione alla costruzione ed all'impiego di ponteggi fissi. Collegati
Ponteggi fissi: quadro normativo
Leggi tutto
Dic 02, 2022 41

Decreto Legislativo 4 agosto 1999 n. 359

Decreto Legislativo 4 agosto 1999 n. 359 Attuazione della direttiva 95/63/CE che modifica la direttiva 89/655/CEE relativa ai requisiti minimi di sicurezza e salute per l'uso di attrezzature di lavoro da parte dei lavoratori. (GU n.246 del 19.10.1999) Collegati[box-note]Direttiva 95/63/CEDirettiva… Leggi tutto
Circolare MI n  1689 del 01 04 2011
Dic 02, 2022 45

Circolare Min. Interno n. 1689 del 01.04.2011

Circolare Min. Interno n. 1689 del 01.04.2011 Locali di pubblico spettacolo di tipo temporaneo o permanente. Verifica della solidità e sicurezza dei carichi sospesi. Le Commissioni di vigilanza istituite per l' applicazione dell'art. 80 del TULPS Regio Decreto 18 giugno 1931 n. 773 hanno, tra l'… Leggi tutto
Dic 02, 2022 67

Decreto Ministeriale 2 settembre 1968

Decreto Ministeriale 2 settembre 1968 - Misure tecniche di sicurezza per i ponteggi metallici fissi ID 18267 | 02.12.2022 Decreto Ministeriale 2 settembre 1968 - Riconoscimento di efficacia di alcune misure tecniche di sicurezza per i ponteggi metallici fissi, sostitutive di quelle indicate nel… Leggi tutto

Più letti Sicurezza